| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0641-6261-01 | 0641-6261 | HUMAN PRESCRIPTION DRUG | Sodium Acetate | Sodium Acetate | INJECTION | INTRAVENOUS | 20240520 | N/A | ANDA | ANDA216920 | Hikma Pharmaceuticals USA Inc. | SODIUM ACETATE ANHYDROUS | 164 mg/mL | 1 VIAL in 1 CARTON (0641-6261-01) / 20 mL in 1 VIAL |
| 0641-6262-01 | 0641-6262 | HUMAN PRESCRIPTION DRUG | Sodium Acetate | Sodium Acetate | INJECTION | INTRAVENOUS | 20240520 | N/A | ANDA | ANDA216920 | Hikma Pharmaceuticals USA Inc. | SODIUM ACETATE ANHYDROUS | 164 mg/mL | 1 VIAL in 1 CARTON (0641-6262-01) / 50 mL in 1 VIAL |
| 0641-6263-10 | 0641-6263 | HUMAN PRESCRIPTION DRUG | Sodium Acetate | Sodium Acetate | INJECTION | INTRAVENOUS | 20240520 | N/A | ANDA | ANDA216920 | Hikma Pharmaceuticals USA Inc. | SODIUM ACETATE ANHYDROUS | 164 mg/mL | 10 VIAL in 1 CARTON (0641-6263-10) / 100 mL in 1 VIAL (0641-6263-01) |